Skip to content

Nexalin Technology, Inc.

NXL

CIK 0001527352 · Electromedical & Electrotherapeutic Apparatus · Nasdaq

← back to feed
Revenue (TTM)
$144.7K
+78.8% YoY Q1 May 2026
Net Income (TTM)
−$7.94M
−8.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.49
+39.8% YoY Q1 May 2026
Gross Margin
70.9%
Q1 May 2026
Operating Margin
-5,596.1%
Q1 May 2026
Net Margin
-5,488.8%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$1.21M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
20.58M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings